Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
5.25
-0.04 (-0.76%)
At close: Dec 5, 2025, 4:00 PM EST
5.44
+0.19 (3.56%)
After-hours: Dec 5, 2025, 7:51 PM EST
Evaxion Market Cap
Evaxion has a market cap or net worth of $43.59 million as of December 5, 2025. Its market cap has increased by 376.36% in one year.
Market Cap
43.59M
Enterprise Value
33.02M
1-Year Change
376.36%
Ranking
Category
Stock Price
$5.25
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $43.59M, a decrease of -77.30%. That is a compound annual growth rate of -26.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 43.59M | 778.96% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |